International Murex Corp. of Toronto is negotiating to acquirethe diagnostics business of The Wellcome Foundation Ltd., thecompanies announced on Tuesday. Potential terms were notdisclosed.

The possible acquisition of Wellcome Diagnostics, based in theUnited Kingdom, is part of Murex's strategy for building adiversified, international diagnostics company. In September,it acquired Amtec Diagnostics International of Houston, makerof blood-typing products.

Murex's other operating units include Dominion Biologicals Ltd.of Canada and Murex Corp. of Norcross, Ga.

The company's stock (AMEX:MXX) closed Tuesday at $10.88, up 63cents.

(c) 1997 American Health Consultants. All rights reserved.